Epidemiology and Risk Factors for Alcoholic Liver Disease -- Global Epidemiology and Risk Factors for Non-Alcoholic Fatty Liver Disease -- Pathogenesis of Alcoholic Liver Disease -- Pathogenesis of NAFLD and NASH -- Animal Models of Alcoholic Liver Disease -- Animal Models of Nonalcoholic Fatty Liver Disease -- Genetic Basis of Alcoholic and Nonalcoholic Fatty Liver Disease -- Clinical Features, Disease Modifiers and Natural History of Alcoholic Liver Disease -- Nonalcoholic Fatty Liver Disease (NAFLD): Clinical Features, Disease Modifiers, and Natural History -- Diagnostic Approaches and Clinical Endpoints of Treatment in Alcoholic Liver Disease -- Diagnostic Considerations and Clinical Endpoints for Nonalcoholic Steatohepatitis -- Pathology of Alcoholic and Non-Alcoholic Fatty Liver Disease -- Hepatic and Extra-Hepatic Malignancies in Alcoholic Liver Disease -- Hepatic and Extra-Hepatic Malignancies in NAFLD -- Treatment of Alcoholic Liver Disease Including Emerging therapies, Novel targets and Liver transplantation -- Current and Emerging Therapies for Non-Alcoholic Fatty Liver Disease -- Nonalcoholic Fatty Liver Disease in Children.

This volume is the first text to concisely yet comprehensively cover developments for both alcoholic and non-alcoholic fatty liver disease in an organized fashion. Aspects of these two diseases covered in the book include global epidemiology and risk factors, pathogenesis, animal models, hepatic and extra-hepatic malignancies, treatment models, and current and emerging therapies. Written by experts in the field, Alcoholic and Non-Alcoholic Fatty Liver Disease: Bench to Bedside is a valuable resource for gastroenterologists, pathologists, and hepatologists who treat patients with alcoholic and nonalcoholic fatty liver disease.